Market Cap 4.55B
Revenue (ttm) 5.00B
Net Income (ttm) 211.82M
EPS (ttm) N/A
PE Ratio 19.65
Forward PE 18.55
Profit Margin 4.24%
Debt to Equity Ratio 0.82
Volume 1,098,300
Avg Vol 1,867,536
Day's Range N/A - N/A
Shares Out 162.30M
Stochastic %K 67%
Beta 0.88
Analysts Strong Sell
Price Target $37.64

Company Profile

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, includin...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 312 940 2443
Address:
3000 Lakeside Drive, Suite 300N, Bannockburn, United States
ADSlay
ADSlay Oct. 24 at 4:26 PM
$QNCX there are big 'reputation' costs associated for public companies to be partnering with others. They don't just randomly partner with small companies unless there is moat, especially not with someone like $QNCX who is a turnaround story, pre-revenue, and no proven product. I am sure $OPCH must've agreed to partner only after performing their thorough due-diligence. yes, no one refuses extra revenue coming in, but when you're a responsible $5 billion publicly traded company, you don't just randomly partner with anyone. there is a 'brand' image they've to protect.
0 · Reply
ADSlay
ADSlay Oct. 23 at 5:03 PM
$QNCX Anything can happen in biotech world, but why would a $5 billion company like $OPCH agree to a strategic partnership with a $100 million company like $QNCX? That alone makes $QNCX a great risk:reward opportunity besides being a Ph3 asset that has full Regulatory support from FDA.
2 · Reply
ADSlay
ADSlay Oct. 23 at 1:12 PM
Thanks for sharing. Yes, $QNCX Management regularly updates their presentation and is a great resource for research. Why would a $5 billion company associate with a $100 million company? Think why $OPCH would partner with $QNCX ? When one is such a big company, one doesn't associate with random biotech microcaps with unproven product. Think about it.
1 · Reply
Estimize
Estimize Oct. 22 at 12:06 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
nikitatrades
nikitatrades Oct. 17 at 1:34 PM
Morgan Stanley initiates $OPCH at Overweight, seeing the company as the key player to benefit from the shift of infusion care into the home and alternative sites.
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 11:55 AM
Morgan Stanley has updated their rating for Option Care Health ( $OPCH ) to Overweight with a price target of 35.
0 · Reply
Invest2live
Invest2live Oct. 8 at 11:28 PM
$HPE 52% already; congrats 🎊 🎉🎈 Checkout $QXO and $OPCH
0 · Reply
BeigeBook
BeigeBook Oct. 5 at 3:47 PM
$OPCH Healthcare technology growth. Testing resistance level. Volume confirmation needed. Sector momentum building.
0 · Reply
JarvisFlow
JarvisFlow Oct. 2 at 2:10 PM
TD Cowen has adjusted their stance on Option Care Health ( $OPCH ), setting the rating to Hold with a target price of 30.
0 · Reply
Estimize
Estimize Sep. 29 at 12:03 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
Latest News on OPCH
Option Care Health Announces Chief Financial Officer Transition

Aug 20, 2025, 8:45 AM EDT - 2 months ago

Option Care Health Announces Chief Financial Officer Transition


Option Care Health, Inc. (OPCH) Q2 2025 Earnings Call Transcript

Jul 30, 2025, 12:01 PM EDT - 3 months ago

Option Care Health, Inc. (OPCH) Q2 2025 Earnings Call Transcript


Option Care Health, Inc. (OPCH) Q1 2025 Earnings Call Transcript

Apr 29, 2025, 12:29 PM EDT - 6 months ago

Option Care Health, Inc. (OPCH) Q1 2025 Earnings Call Transcript


Option Care Health, Inc. (OPCH) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 1:16 PM EST - 8 months ago

Option Care Health, Inc. (OPCH) Q4 2024 Earnings Call Transcript


Option Care Health: A Deep Dive Into Its Market Dominance

May 31, 2024, 11:50 AM EDT - 1 year ago

Option Care Health: A Deep Dive Into Its Market Dominance


Option Care Health says it is affected by UnitedHealth hack

Mar 14, 2024, 5:04 PM EDT - 1 year ago

Option Care Health says it is affected by UnitedHealth hack

UNH


ADSlay
ADSlay Oct. 24 at 4:26 PM
$QNCX there are big 'reputation' costs associated for public companies to be partnering with others. They don't just randomly partner with small companies unless there is moat, especially not with someone like $QNCX who is a turnaround story, pre-revenue, and no proven product. I am sure $OPCH must've agreed to partner only after performing their thorough due-diligence. yes, no one refuses extra revenue coming in, but when you're a responsible $5 billion publicly traded company, you don't just randomly partner with anyone. there is a 'brand' image they've to protect.
0 · Reply
ADSlay
ADSlay Oct. 23 at 5:03 PM
$QNCX Anything can happen in biotech world, but why would a $5 billion company like $OPCH agree to a strategic partnership with a $100 million company like $QNCX? That alone makes $QNCX a great risk:reward opportunity besides being a Ph3 asset that has full Regulatory support from FDA.
2 · Reply
ADSlay
ADSlay Oct. 23 at 1:12 PM
Thanks for sharing. Yes, $QNCX Management regularly updates their presentation and is a great resource for research. Why would a $5 billion company associate with a $100 million company? Think why $OPCH would partner with $QNCX ? When one is such a big company, one doesn't associate with random biotech microcaps with unproven product. Think about it.
1 · Reply
Estimize
Estimize Oct. 22 at 12:06 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
nikitatrades
nikitatrades Oct. 17 at 1:34 PM
Morgan Stanley initiates $OPCH at Overweight, seeing the company as the key player to benefit from the shift of infusion care into the home and alternative sites.
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 11:55 AM
Morgan Stanley has updated their rating for Option Care Health ( $OPCH ) to Overweight with a price target of 35.
0 · Reply
Invest2live
Invest2live Oct. 8 at 11:28 PM
$HPE 52% already; congrats 🎊 🎉🎈 Checkout $QXO and $OPCH
0 · Reply
BeigeBook
BeigeBook Oct. 5 at 3:47 PM
$OPCH Healthcare technology growth. Testing resistance level. Volume confirmation needed. Sector momentum building.
0 · Reply
JarvisFlow
JarvisFlow Oct. 2 at 2:10 PM
TD Cowen has adjusted their stance on Option Care Health ( $OPCH ), setting the rating to Hold with a target price of 30.
0 · Reply
Estimize
Estimize Sep. 29 at 12:03 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
Invest2live
Invest2live Sep. 24 at 4:19 PM
$OPCH excellent value; do your dd and get in.
0 · Reply
Ka1ch123
Ka1ch123 Sep. 24 at 4:22 AM
$OPCH great entry point
0 · Reply
JarvisFlow
JarvisFlow Sep. 23 at 3:21 PM
Barrington Research has adjusted their stance on Option Care Health ( $OPCH ), setting the rating to Outperform with a target price of 38.
0 · Reply
Djohn2012
Djohn2012 Sep. 17 at 4:56 PM
$OPCH Low PE stock. 2 Yr. Forward PE 14.5 This may go much higher
0 · Reply
notreload_ai
notreload_ai Sep. 17 at 1:33 PM
$OPCH leads home infusion therapy, a booming market. They offer convenient, cost-effective care for chronic illnesses. With strong financials, strategic growth, and national reach, it's a top player and potentially undervalued investment. https://www.barrons.com/articles/buy-option-care-health-stock-price-pick-1e20146a
0 · Reply
TheAlmani
TheAlmani Sep. 17 at 10:13 AM
$OPCH Same Barron‘s author who recommended $INOD now recommends to buy OPCH. I am nervous as hell!
1 · Reply
Estimize
Estimize Sep. 15 at 12:03 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
Grouphome
Grouphome Sep. 8 at 6:47 PM
$OPCH new long
0 · Reply
Estimize
Estimize Sep. 1 at 12:06 PM
Wall St is expecting 0.43 EPS for $OPCH Q3 [Reporting 10/30 BMO] http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_co
0 · Reply
ADSlay
ADSlay Aug. 7 at 11:49 PM
$QNCX asked Grok basic questions: - did $OPCH conduct a thorough analysis of $QNCX? - would $OPCH still have partnered with $QNCX if it had found there was nothing in it for them after doing a thorough analysis? make what you will
0 · Reply
ADSlay
ADSlay Aug. 7 at 4:38 PM
$QNCX Wow! A $90 million market cap company, $QNCX, collaborating with a $4.5 billion company, $OPCH! Congrats! I like where this is going 🚀
1 · Reply
Estimize
Estimize Jul. 30 at 10:01 PM
$OPCH reported 0.41 EPS and 1,416 revenue for Q2. http://www.estimize.com/intro/opch?chart=historical&metric_name=eps&utm_content=OPCH&utm_
0 · Reply